Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 5,396Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Dr. Reddy's Laboratories

02 2Accord healthcare

03 1Aurobindo Pharma Limited

04 23Boehringer Ingelheim GmbH

05 2Captavis Biocare

06 1Glenmark Pharmaceuticals

07 2Intas Pharmaceuticals

08 2Lotus Pharmaceutical

09 2Olon S.p.A

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Nintedanib Esylate

Brand Name :

Dosage Form : Oral Solid Dosage Form

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Nintedanib Esylate

Brand Name :

Dosage Form : Oral Solid Dosage Form

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Dr Reddy Company Banner

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date :

Application Number : 212732

Regulatory Info :

Registration Country : USA

blank

04

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date :

Application Number : 212732

Regulatory Info :

Registration Country : USA

blank

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date :

Application Number : 215123

Regulatory Info :

Registration Country : USA

blank

06

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

NINTEDANIB ESYLATE

Brand Name : OFEV

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2014-10-15

Application Number : 205832

Regulatory Info : RX

Registration Country : USA

blank

07

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

NINTEDANIB ESYLATE

Brand Name : OFEV

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2014-10-15

Application Number : 205832

Regulatory Info : RX

Registration Country : USA

blank

08

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

nintedanibesilat

Brand Name : Ofev

Dosage Form : SOFT CAPSULE

Dosage Strength : 150 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

09

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

nintedanibesilat

Brand Name : Ofev

Dosage Form : SOFT CAPSULE

Dosage Strength : 100 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

10

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

nintedanibesilat

Brand Name : Vargatef

Dosage Form : KAPSEL, MJUK

Dosage Strength : 100 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

11

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

nintedanibesilat

Brand Name : Vargatef

Dosage Form : KAPSEL, MJUK

Dosage Strength : 150 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

12

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Vargatef

Brand Name : Ofev

Dosage Form : Nintedanib 100Mg 60 Units Oral Use

Dosage Strength : 1x60 soft cps 100 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

13

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Vargatef

Brand Name : Ofev

Dosage Form : Nintedanib 150Mg 60 Units Oral Use

Dosage Strength : 1x60 soft cps 150 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

14

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Vargatef

Brand Name : Ofev

Dosage Form : Capsule, soft

Dosage Strength : 100 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

15

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Vargatef

Brand Name : Ofev

Dosage Form : Capsule, soft

Dosage Strength : 150 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

16

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Vargatef

Brand Name : Vargatef

Dosage Form : Capsule, soft

Dosage Strength : 100 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

17

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Vargatef

Brand Name : Vargatef

Dosage Form : Capsule, soft

Dosage Strength : 100 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

18

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

NINTEDANIB ESYLATE

Brand Name : NINTEDANIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date :

Application Number : 212555

Regulatory Info :

Registration Country : USA

blank

19

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 216915

Regulatory Info :

Registration Country : USA

blank

20

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

NINTEDANIB

Brand Name : NINTEDANIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number : 216915

Regulatory Info :

Registration Country : USA

blank